AMICUS THERAPEUTICS, INC. Annual Interest Expense in USD from 2010 to 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of the cost of borrowed funds accounted for as interest expense.
Summary: Amicus Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2010 to 2023.
Amicus Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $12.4M, a 5% increase year-over-year.
Amicus Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $50.7M, a 24.3% increase year-over-year.
Amicus Therapeutics, Inc. annual Interest Expense for 2023 was $50.1M, a 35.1% increase from 2022.
Amicus Therapeutics, Inc. annual Interest Expense for 2022 was $37.1M, a 14.3% increase from 2021.
Amicus Therapeutics, Inc. annual Interest Expense for 2021 was $32.5M, a 44.8% increase from 2020.

Interest Expense, Trailing 12 Months (USD)

Interest Expense, Annual (USD)

Interest Expense, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	$50.1M	+$13M	+35.1%	Jan 1, 2023	Dec 31, 2023	10-K	2024-02-28
2022	$37.1M	+$4.65M	+14.3%	Jan 1, 2022	Dec 31, 2022	10-K	2024-02-28
2021	$32.5M	+$10M	+44.8%	Jan 1, 2021	Dec 31, 2021	10-K	2024-02-28
2020	$22.4M	+$3.55M	+18.8%	Jan 1, 2020	Dec 31, 2020	10-K	2023-03-01
2019	$18.9M	-$3.53M	-15.8%	Jan 1, 2019	Dec 31, 2019	10-K	2022-02-24
2018	$22.4M	+$5.16M	+29.9%	Jan 1, 2018	Dec 31, 2018	10-K	2021-03-01
2017	$17.2M	+$11.8M	+219%	Jan 1, 2017	Dec 31, 2017	10-K	2020-03-02
2016	$5.4M	+$3.82M	+242%	Jan 1, 2016	Dec 31, 2016	10-K	2019-02-28
2015	$1.58M	+$94K	+6.33%	Jan 1, 2015	Dec 31, 2015	10-K	2018-03-01
2014	$1.48M	+$1.44M	+3126%	Jan 1, 2014	Dec 31, 2014	10-K/A	2017-03-03
2013	$46K	-$43K	-48.3%	Jan 1, 2013	Dec 31, 2013	10-K	2016-02-29
2012	$89K	-$59K	-39.9%	Jan 1, 2012	Dec 31, 2012	10-K	2015-03-03
2011	$148K	-$112K	-43.1%	Jan 1, 2011	Dec 31, 2011	10-K	2014-03-03
2010	$260K			Jan 1, 2010	Dec 31, 2010	10-K	2013-03-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.